Influence of Locus on PFA-100 Collagen-ADP Closure Time Is Not Totally Dependent on the Von Willebrand Factor. Results of a GWAS on GAIT-2 Project Phenotypes

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Jul 3

PMID 31262040

Citations 9

Authors

Nuria Pujol-Moix

Angel Martinez-Perez

Maria Sabater-Lleal

Dolors Llobet

Noelia Vilalta

Anders Hamsten

Joan Carles Souto

Jose Manuel Soria

Affiliations

Soon will be listed here.

Abstract

(1) Background: In a previous study, we found that two phenotypes related to platelet reactivity, measured with the PFA-100 system, were highly heritable. The aim of the present study was to identify genetic determinants that influence the variability of these phenotypes: closure time of collagen-ADP (Col-ADP) and of collagen-epinephrine (Col-Epi). (2) Methods: As part of the GAIT-2 (Genetic Analysis of Idiopathic Thrombophilia (2) Project, 935 individuals from 35 large Spanish families were studied. A genome-wide association study (GWAS) with ≈ 10 M single nucleotide polymorphisms (SNPs) was carried out with Col-ADP and Col-Epi phenotypes. (3) Results: The study yielded significant genetic signals that mapped to the locus. After adjusting both phenotypes for the genotype, these signals disappeared. After adjusting for von Willebrand factor (VWF) or for coagulation factor VIII (FVIII), the significant signals disappeared totally for Col-Epi phenotype but only partially for Col-ADP phenotype. (4) Conclusion: Our results suggest that the locus exerts the main genetic influence on PFA-100 phenotypes. However, while the effect of the locus on Col-Epi phenotype is mediated through VWF and/or FVIII, the effect of the locus on Col-ADP phenotype is partly produced through VWF and/or FVIII, and partly through other mechanisms.

Citing Articles

Non-O blood types are associated with a greater risk of large artery atherosclerosis stroke and dysregulation of cholesterol metabolism: an observational study.

Gou L, Li H, Jiang Y, Liu Y, Gu H, Xu Z Lipids Health Dis. 2024; 23(1):211.

PMID: 38965603 PMC: 11223365. DOI: 10.1186/s12944-024-02199-6.

Comprehensive analysis of platelet glycoprotein Ibα ectodomain glycosylation.

Hollenhorst M, Tiemeyer K, Mahoney K, Aoki K, Ishihara M, Lowery S J Thromb Haemost. 2023; 21(4):995-1009.

PMID: 36740532 PMC: 10065957. DOI: 10.1016/j.jtha.2023.01.009.

Gestational Diabetes Melitus and Cord Blood Platelet Function Studied via the PFA-100 System.

Mougiou V, Boutsikou T, Sokou R, Kollia M, Valsami S, Pouliakis A Diagnostics (Basel). 2022; 12(7).

PMID: 35885550 PMC: 9318840. DOI: 10.3390/diagnostics12071645.

Platelet Dysfunction in Blood Donors Detected by Platelet Function Analyzer PFA-100™.

Belkacemi M, Berber A Cureus. 2022; 14(5):e25497.

PMID: 35783880 PMC: 9242643. DOI: 10.7759/cureus.25497.

Variables that Influence Platelet Function Analyzer-100™ Closure Times in Healthy Algerian Adults.

Belkacemi M, Merad Y Int J Appl Basic Med Res. 2021; 11(3):154-159.

PMID: 34458117 PMC: 8360221. DOI: 10.4103/ijabmr.IJABMR_532_20.

References

Souto J, Almasy L, Muniz-Diaz E, Soria J, Borrell M, Bayen L . Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol. 2000; 20(8):2024-8. DOI: 10.1161/01.atv.20.8.2024. View

Souto J, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria J . Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet. 2000; 67(6):1452-9. PMC: 1287922. DOI: 10.1086/316903. View

Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V . Influence of ABO blood groups on primary hemostasis. Transfusion. 2001; 41(1):56-60. DOI: 10.1046/j.1537-2995.2001.41010056.x. View

Lippi G, Franchini M . Laboratory screening for abnormalities of primary hemostasis: what's next?. Clin Chem. 2001; 47(11):2071. View

Zhong X, Kriz R, Seehra J, Kumar R . N-linked glycosylation of platelet P2Y12 ADP receptor is essential for signal transduction but not for ligand binding or cell surface expression. FEBS Lett. 2004; 562(1-3):111-7. DOI: 10.1016/S0014-5793(04)00191-7. View

Harrison P . The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol. 2005; 130(1):3-10. DOI: 10.1111/j.1365-2141.2005.05511.x. View

Hayward C, Harrison P, Cattaneo M, Ortel T, Rao A . Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost. 2006; 4(2):312-9. DOI: 10.1111/j.1538-7836.2006.01771.x. View

Fuchs I, Frossard M, Spiel A, Riedmuller E, Laggner A, Jilma B . Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J Thromb Haemost. 2006; 4(12):2547-52. DOI: 10.1111/j.1538-7836.2006.02239.x. View

Reny J, de Moerloose P, Dauzat M, Fontana P . Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost. 2008; 6(3):444-50. DOI: 10.1111/j.1538-7836.2008.02897.x. View

10.

Favaloro E . Clinical utility of the PFA-100. Semin Thromb Hemost. 2009; 34(8):709-33. DOI: 10.1055/s-0029-1145254. View

11.

Tregouet D, Heath S, Saut N, Biron-Andreani C, Schved J, Pernod G . Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood. 2009; 113(21):5298-303. DOI: 10.1182/blood-2008-11-190389. View

12.

Nazarian S, Thompson J, Gluckman T, Laws K, Jani J, Kickler T . Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy. Thromb Res. 2009; 126(5):379-83. PMC: 2975867. DOI: 10.1016/j.thromres.2009.04.016. View

13.

Howie B, Donnelly P, Marchini J . A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009; 5(6):e1000529. PMC: 2689936. DOI: 10.1371/journal.pgen.1000529. View

14.

Favaloro E, Thom J, Patterson D, Just S, Baccala M, Dixon T . Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease. Blood Coagul Fibrinolysis. 2009; 20(6):475-83. DOI: 10.1097/MBC.0b013e32832da1ad. View

15.

Paterson A, Lopes-Virella M, Waggott D, Boright A, Hosseini S, Carter R . Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol. 2009; 29(11):1958-67. PMC: 3147250. DOI: 10.1161/ATVBAHA.109.192971. View

16.

Barbalic M, Dupuis J, Dehghan A, Bis J, Hoogeveen R, Schnabel R . Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet. 2010; 19(9):1863-72. PMC: 2850624. DOI: 10.1093/hmg/ddq061. View

17.

Smith N, Chen M, Dehghan A, Strachan D, Basu S, Soranzo N . Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010; 121(12):1382-92. PMC: 2861278. DOI: 10.1161/CIRCULATIONAHA.109.869156. View

18.

Johnson A, Yanek L, Chen M, Faraday N, Larson M, Tofler G . Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet. 2010; 42(7):608-13. PMC: 3057573. DOI: 10.1038/ng.604. View

19.

Reilly M, Li M, He J, Ferguson J, Stylianou I, Mehta N . Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011; 377(9763):383-92. PMC: 3297116. DOI: 10.1016/S0140-6736(10)61996-4. View

20.

Schunkert H, Konig I, Kathiresan S, Reilly M, Assimes T, Holm H . Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011; 43(4):333-8. PMC: 3119261. DOI: 10.1038/ng.784. View